TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    The Long Run with Luke Timmerman

    “The Long Run”

    Antarctic explorer Ernest Shackleton would appreciate today’s biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

    Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Advertise

    Copyright: © All rights reserved

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Ep190: Neil Kumar on Building a Rare Disease Drug Company Nov 20, 2025
    Show notes

    Neil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.


    Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI Nov 12, 2025
    Show notes

    Marc Tessier-Lavigne, CEO of South San Francisco-based Xaira Therapeutics, on reinventing drug discovery with AI.


    Ep188: Art Krieg on Innate Immune System Activators for Cancer Oct 28, 2025
    Show notes

    Art Krieg, founder and CEO of Zola Therapeutics, on developing innate immune system activators for cancer.


    Ep187: Eric Fischer on Creating a New Class of Medicines Oct 14, 2025
    Show notes

    Eric Fischer, a professor at Dana-Farber Cancer Institute, on creating a new class medicines -- targeted protein degraders.


    Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope Sep 29, 2025
    Show notes

    Bruce Levine, a CAR-T cell therapy researcher at the University of Pennsylvania, and Mags McCarthy, a country music star, discuss their new song about science and hope for cancer patients.


    Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale Sep 17, 2025
    Show notes

    Dr. Lachelle Weeks is a physician-scientist at Dana-Farber Cancer Institute working on a project to predict leukemia risk based on widely available blood samples.


    Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies Aug 28, 2025
    Show notes

    Jen Adair, professor and associate director of the Horae Gene Therapy Center at the University of Massachusetts Chan Medical School, on creating more affordable and accessible cell and gene therapies.


    Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors Aug 06, 2025
    Show notes

    Sabah Oney, CEO of Philadelphia and San Francisco-based Dispatch Biotherapeutics, on engineering CAR-T cells that can kill solid tumors.


    Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science Jul 23, 2025
    Show notes

    Andy Rachleff and Yung Lie, board chair and CEO of Damon Runyon Cancer Research Foundation, on creative ways to support science amid budget cuts.


    Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer Jul 01, 2025
    Show notes

    Claire Mazumdar, CEO of Boston-based Bicara Therapeutics, on developing a bifunctional antibody for head and neck cancer.


    Previous 1 2 3 4 5 21 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights